We recently reported that high NECTIN4 expression is associated with a poor prognosis of skin tumors such as extramammary Paget’s disease and malignant melanoma, and suggested the potential of NECTIN4 as a target in skin cancer therapy [31,32]. Here, NECTIN4 is linked to skin neoplasm.